Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progression
Titel:
Key decision factors in second-line therapy: Expert insights on HR+/HER2-metastatic breast cancer post-CDK4/6 inhibitor progression
Auteur:
Buonaiuto, Roberto Botticelli, Andrea Criscitiello, Carmen Dieci, Maria Vittoria Fusco, Nicola Gerratana, Lorenzo Lambertini, Matteo Malapelle, Umberto Malorni, Luca De Angelis, Carmine